While SPP1+ TAMs are known to promote tumor progression through immunosuppressive mechanisms [15,16,17,18,19], the SPP1+BCL2A1+ TAM subset further exhibits a distinct transcriptional program associated with resistance to cell death. This evidence concerns the gene BCL2A1 and neoplasm.